We aim to improve patient outcome following
trauma, transplantation or heart surgery as
well as reducing the general cost of treatment
and usage of blood products through differential diagnosis, targeted therapy and monitoring.
We do this through the development,
manufacture and sales of medical diagnostic
devices designed to manage acute and
massive bleeding situations at the
patients point of care.
We aim to understand our customers needs
through the regular exchange of information
with key opinion leaders, distribution partners
and customers themselves. Through this we
develop new products and services suited to
those specific customer requirements.